
Oliver Zill, data scientist, Guardant Health, discusses the somatic genomic landscape of over 15,000 patients with advanced-stage cancer from clinical next-generation sequencing analysis of circulating tumor DNA.

Your AI-Trained Oncology Knowledge Connection!


Published: September 26th 2016 | Updated: